DuPont de Nemours, Inc.

$19.00

SKU: DD Category:

Description

DuPont’s de Nemours’ New Growth Strategy — Will Healthcare, Water, & Electronics Deliver?

 

DuPont reported its second quarter 2025 financial results, highlighting a robust performance marked by organic sales growth and increased profitability. Sales reached $3.3 billion, reflecting a 2% organic growth compared to the previous year, while operating EBITDA increased by 8% to $859 million. This resulted in an EBITDA margin of 26.4%, up 120 basis points year-over-year. Adjusted EPS also rose 15% to $1.12, prompting the company to raise its full-year earnings guidance.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!